# Condylox

NDC: 0023-6118
Generic name: podofilox
Labeler / Manufacturer: Allergan, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 19970313
Marketing ended: 20261031
FDA application: NDA020529

## Active ingredients

- PODOFILOX: 5 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0023-6118"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0023-6118
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=032e4bcb-b1ed-4029-b2a6-e92f3bf5cc37